Tag: Office of Policy Planning

Displaying 21 - 40 of 124 results.

Federal Trade Commission staff has issued a policy paper suggesting that state legislators should be cautious when evaluating proposals to limit the scope of practice of Advanced Practice Registered Nurses (APRNs). By limiting the range of services APRNs may provide and the extent to which they...
The Federal Trade Commission will host a two-day workshop on March 20-21, 2014, at its Conference Center at 601 New Jersey Ave., N.W., in Washington, DC, to examine competition issues related to certain current developments in the U.S. health care industry. Health care spending accounts for a...
When was your last health exam? Just as we (are supposed to) get regular check-ups from our health care providers, the FTC thinks it is smart to do a periodic check-up on the health care industry itself. Health care is a critical sector of the U.S. economy, affecting the lives of all...
The Federal Trade Commission held a public workshop to study certain activities and trends that may affect competition in the evolving health care industry. The workshop explored current developments related to:
A few minutes ago, FTC Chairwoman Edith Ramirez delivered opening remarks to kick off today’s FTC workshop exploring emerging issues affecting competition and patient access to biologic medicines. You can view a live webcast of the workshop on the FTC’s website, or follow live tweets...
The Federal Trade Commission is hosting a workshop on competition issues surrounding biologics and follow-on biologic medicines on Feb. 4, 2014, in Washington, DC, and invites live webcast viewers to submit questions to moderators online.
Tomorrow, the FTC will host a workshop to explore emerging issues affecting competition and consumer access to biologic medicines.
Forces of globalization and innovation that have been rippling through our economy for more than 200 years are now ripping up the established terrain of many economic sectors. Whether driven by improvements in computers, biotechnology, communications or other technologies, tumbling...
The Federal Trade Commission today issued the final agenda for its one-day public workshop on competition and follow-on biologics, which will be held on February 4 at its Conference Center located at 601 New Jersey Ave., NW, in Washington, DC.
Federal Trade Commission staff, in response to a request from Massachusetts State Representative Kay Khan, provided comments on Massachusetts House Bill 2009, stating that, as proposed, the elimination of certain supervision requirements for nurse practitioners (NPs) and nurse anesthetists (NAs)...
This will come as no shock to anyone familiar with the Federal Trade Commission’s policy and advocacy function: FTC staff has a long history of advocating for effective competition and consumer protection in electricity markets.
The Federal Trade Commission staff submitted a reply comment in response to a request from the District of Columbia Public Service Commission (DC PSC) for comments on Potomac Electric Power Company’s (Pepco’s) proposed dynamic pricing program for residential customers.
The Federal Trade Commission announced its one-day public workshop on competition and follow-on biologics has been rescheduled for Feb. 4, 2014. The workshop will be held at the FTC’s Conference Center located at 601 New Jersey Ave., NW, in Washington, and will examine competition issues...
Due to inclement weather and the closure of the federal government for today, the Federal Trade Commission has postponed until further notice its one-day public workshop on Follow-On Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition.
When faced with a major illness, patients usually want the best medicine available, regardless of cost. In some cases, next-generation “biologic” medicines may be the best treatments available. Unfortunately, these critical treatments can be very expensive. For example, Herceptin,...
Welcome to Competition Matters, the FTC’s newest blog for all things competition. We hope to become your go-to spot for the latest insights and events from the Bureau of Competition, the Bureau of Economics, and the Office of Policy Planning. We’ll also have occasional missives from...
The Federal Trade Commission has announced the agenda for the upcoming public roundtable on “Follow-on Biologics: Impact of Recent Legislative and Regulatory Naming Proposals on Competition.” The workshop will be held in the FTC Conference Center at 601 New Jersey Ave., N.W., in Was
The Federal Trade Commission has extended the deadline for public comments on its proposed study of patent assertion entities (PAEs), which it announced on September 27.  To provide additional time for interested parties to submit comments on the proposed study, the deadline has been extended...
The Federal Trade Commission held a workshop to explore competition issues involving biologic medicines and follow-on biologics. As described in the Federal Register Notice, the workshop focused on a few key issues, inter alia:

Pages